Zenas BioPharma, Inc. Accumulated Other Comprehensive Income
Zenas BioPharma, Inc. (ZBIO) had Accumulated Other Comprehensive Income of -$1.14 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-13
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$1.14M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$377.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$64.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$69.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$1.14M 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$377.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | -$64.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$69.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$94.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $141.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $194.00K 10-K · filed 2026-03-16 |
| 2024-09-30 | $54.00K 10-Q · filed 2024-11-12 |
| 2023-12-31 | $37.00K 10-K · filed 2025-03-11 |